QSAR Implementation for HIC Retention Time Prediction of mAbs Using Fab Structure: A Comparison between Structural Representations
Monoclonal antibodies (mAbs) constitute a rapidly growing biopharmaceutical sector. However, their growth is impeded by high failure rates originating from failed clinical trials and developability issues in process development. There is, therefore, a growing need for better in silico tools to aid i...
Main Authors: | Micael Karlberg, João Victor de Souza, Lanyu Fan, Arathi Kizhedath, Agnieszka K. Bronowska, Jarka Glassey |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/21/8037 |
Similar Items
-
Applicability of Traditional In Vitro Toxicity Tests for Assessing Adverse Effects of Monoclonal Antibodies: A Case Study of Rituximab and Trastuzumab
by: Arathi Kizhedath, et al.
Published: (2018-08-01) -
Developments and Challenges for mAb-Based Therapeutics
by: Satoshi Ohtake, et al.
Published: (2013-08-01) -
The Different Colors of mAbs in Solution
by: Alexandre Ambrogelly
Published: (2021-05-01) -
Plant Recycling for Molecular Biofarming to Produce Recombinant Anti-cancer mAb
by: Deuk-Su Kim, et al.
Published: (2016-07-01) -
The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs
by: Josée Golay, et al.
Published: (2020-10-01)